𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Iron Metabolism in Nonalcoholic Fatty Liver Disease

✍ Scribed by James E. Nelson; Heather Klintworth; Kris V. Kowdley


Book ID
107539675
Publisher
Springer
Year
2011
Tongue
English
Weight
255 KB
Volume
14
Category
Article
ISSN
1522-8037

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Hepatic iron and nonalcoholic fatty live
✍ Zobair M. Younossi; Terry Gramlich; Bruce R. Bacon; Christi A. Matteoni; Navdeep πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 1 views
Iron and fibrosis in nonalcoholic fatty
✍ Graeme A. Macdonald; Patrick J. Ward; D. Keith George; Lawrie W. Powell πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views
Nonalcoholic fatty liver disease
✍ Zobair M. Younossi πŸ“‚ Article πŸ“… 1999 πŸ› Springer 🌐 English βš– 217 KB
Nonalcoholic fatty liver disease after l
✍ Kanthi Yalamanchili; Sherif Saadeh; GΓΆran B. Klintmalm; Linda W. Jennings; Gary πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 262 KB

Nonalcoholic steatohepatitis (NASH) may account for many cases of cryptogenic cirrhosis. If so, then steatosis might recur after liver transplantation. Two thousand fifty-two patients underwent primary liver transplantation for chronic liver disease between 1986 and 2004. Serial liver biopsy samples

Nonalcoholic fatty liver disease and liv
✍ Paul Angulo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 229 KB

Nonalcoholic fatty liver disease affects a substantial proportion of the general population worldwide. This high prevalence of nonalcoholic fatty liver disease has important consequences in the donor selection process for liver transplantation, and in the posttransplant period given the high recurre

Adipocytokine levels in nonalcoholic fat
✍ Teoman Dogru; Cemal Nuri Ercin; Serkan Tapan; Murat Kantarcioglu; Muammer Kara; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

Li et al. have analyzed golgi phosphoprotein 2 (GOLPH2) serum levels in a cohort of patients with liver cirrhosis, healthy controls, and patients with hepatocellular carcinoma (HCC). They found elevated serum levels of GOLPH2 (sGOLPH2) in early HCC cases. From their findings, the authors conclude th